EWHA WOMANS UNIVERSITY

Kim, Wooseong Associate Professor

Pharmaceutical Sciences/Division of Pharmacy

Pharmaceutical Science Building B #315
02-3277-3372

Research Record

Development of fluorescence-linked immunosorbent assay for rapid detection of Staphylococcus aureus Applied Microbiology and Biotechnology, 2024, v.108 no.1, 1-10
SCIE Scopus dColl.
Maximization of 3-hydroxyhexanoate fraction in poly(3-hydroxybutyrate-co-3-hydroxyhexanoate) using lauric acid with engineered Cupriavidus necator H16 International Journal of Biological Macromolecules, 2024, v.256, 128376
SCIE Scopus dColl.
4-Chloro-2-Isopropyl-5-Methylphenol Exhibits Antimicrobial and Adjuvant Activity against Methicillin-Resistant Staphylococcus aureus Journal of microbiology and biotechnology, 2022, v.32 no.6, 730-739
Scopus dColl.
Antimicrobial activity of the membrane-active compound nTZDpa is enhanced at low pH Biomedicine and Pharmacotherapy, 2022, v.150, 112977
SCIE Scopus dColl.
Arctic Psychrotolerant Pseudomonas sp. B14-6 Exhibits Temperature-Dependent Susceptibility to Aminoglycosides ANTIBIOTICS-BASEL, 2022, v.11 no.8, 1019
SCIE Scopus dColl.
Finding of novel polyhydroxybutyrate producer Loktanella sp. SM43 capable of balanced utilization of glucose and xylose from lignocellulosic biomass International Journal of Biological Macromolecules, 2022, v.208, 809-818
SCIE Scopus dColl.
Flow cytometry-based rapid detection of Staphylococcus aureus and Pseudomonas aeruginosa using fluorescent antibodies RSC Advances, 2022, v.12 no.53, 34660-34669
SCIE Scopus dColl.
Generation of Recombinant Antibodies in HEK293F Cells for the Detection of Staphylococcus aureus ACS Omega, 2022, v.7 no.11, 9690-9700
SCIE Scopus dColl.
Generation of a recombinant antibody for sensitive detection of Pseudomonas aeruginosa BMC Biotechnology, 2022, v.22 no.1, 21
SCIE Scopus dColl.
Inhibition of Cyclopropane Fatty Acid Synthesis in the Membrane of Halophilic Halomonas socia CKY01 by Kanamycin BIOTECHNOLOGY AND BIOPROCESS ENGINEERING, 2022, v.27 no.5, 762-770
SCIE Scopus KCI dColl.
Leucyl-tRNA Synthetase Inhibitor, D-Norvaline, in Combination with Oxacillin, Is Effective against Methicillin-Resistant Staphylococcus aureus Antibiotics, 2022, v.11 no.5, 683
SCIE Scopus dColl.
Study of SarA by DNA Affinity Capture Assay (DACA) Employing Three Promoters of Key Virulence and Resistance Genes in Methicillin-Resistant Staphylococcus aureus Antibiotics, 2022, v.11 no.12, 1714
SCIE Scopus dColl.
Comparative Study of the Difference in Behavior of the Accessory Gene Regulator (Agr) in USA300 and USA400 Community- Associated Methicillin-Resistant Staphylococcus aureus (CA-MRSA) JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, v.31 no.8, 1060-1068
SCIE Scopus KCI dColl.
Increased Antibiotic Resistance of Methicillin-Resistant Staphylococcus aureus USA300 Delta psm Mutants and a Complementation Study of Delta psm Mutants Using Synthetic Phenol-Soluble Modulins JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2021, v.31 no.1, 115-122
SCIE Scopus KCI dColl.
Repurposing Kinase Inhibitor Bay 11-7085 to Combat Staphylococcus aureus and Candida albicans Biofilms Frontiers in Pharmacology, 2021, v.12, 675300
SCIE Scopus dColl.
Wastewater based microalgal biorefinery for bioenergy production: Progress and challenges SCIENCE OF THE TOTAL ENVIRONMENT, 2021, v.751, 141599
SCIE Scopus dColl.
Anti-MRSA agent discovery using Caenorhabditis elegans-based high-throughput screening JOURNAL OF MICROBIOLOGY, 2020, v.58 no.6, 431-444
SCIE Scopus KCI dColl.
Caenorhabditis elegans mounts a p38 MAPK pathway-mediated defence to Cutibacterium acnes infection Cellular Microbiology, 2020, v.22 no.10, e13234
SCIE Scopus dColl.
Combination Therapy Using Low-Concentration Oxacillin with Palmitic Acid and Span85 to Control Clinical Methicillin-Resistant Staphylococcus aureus ANTIBIOTICS-BASEL, 2020, v.9 no.10, 682
SCIE Scopus dColl.
In the model host caenorhabditis elegans, sphingosine-1-phosphate-mediated signaling increases immunity toward human opportunistic bacteria International Journal of Molecular Sciences, 2020, v.21 no.21, 1-16
SCIE Scopus dColl.
Multi-omics based characterization of antibiotic response in clinical isogenic isolates of methicillin-susceptible/-resistantStaphylococcus aureus RSC ADVANCES, 2020, v.10 no.46, 27864-27873
SCIE Scopus dColl.
New antimicrobial bioactivity against multidrugresistant gram-positive bacteria of kinase inhibitor imd0354 Antibiotics, 2020, v.9 no.10, 1-17
SCIE Scopus dColl.
Phenol-Soluble Modulin-Mediated Aggregation of Community-Associated Methicillin-Resistant Staphylococcus Aureus in Human Cerebrospinal Fluid CELLS, 2020, v.9 no.3, 788
SCIE Scopus dColl.
Production of L-Theanine Using Escherichia coli Whole-Cell Overexpressing gamma-Glutamylmethylamide Synthetase with Baker's Yeast JOURNAL OF MICROBIOLOGY AND BIOTECHNOLOGY, 2020, v.30 no.5, 785-792
SCIE Scopus KCI dColl.
Simultaneous monitoring of the bioconversion from lysine to glutaric acid by ethyl chloroformate derivatization and gas chromatography-mass spectrometry ANALYTICAL BIOCHEMISTRY, 2020, v.597, UNSP 113688
SCIE Scopus dColl.
The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus MBIO, 2020, v.11 no.3, e01140-20
SCIE Scopus dColl.
A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, v.116 no.33, 16529-16534
SCIE Scopus dColl.
Auranofin is an effective agent against clinical isolates of Staphylococcus aureus FUTURE MEDICINAL CHEMISTRY, 2019, v.11 no.12, 1417-1425
SCIE Scopus dColl.
[학술지논문] A Methylazanediyl Bisacetamide Derivative Sensitizes Staphylococcus aureus Persisters to a Combination of Gentamicin And Daptomycin ADVANCED SCIENCE, 2024, v.11 no.9 , 2306112-2306112
SCIE
[학술지논문] Mechanics of membrane targeting antimicrobials - Pore nucleation in bacterial membranes MECHANICS OF MATERIALS, 2024, v.193 no.193 , 104991-104991
SCIE
[학술지논문] Development of fluorescence-linked immunosorbent assay for rapid detection of Staphylococcus aureus APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2023, v.108 no.1 , 2-2
SCIE
[학술지논문] Antimicrobial activity of the membrane-active compound nTZDpa is enhanced at low pH BIOMEDICINE & PHARMACOTHERAPY, 2022, v.150 no.0 , 112977-112977
SCI
[학술지논문] Arctic Psychrotolerant Pseudomonas sp. B14-6 Exhibits Temperature-Dependent Susceptibility to Aminoglycosides Antibiotics, 2022, v.11 no.8 , 1019-1019
SCIE
[학술지논문] Repurposing Kinase Inhibitor Bay 11-7085 to Combat Staphylococcus aureus and Candida albicans Biofilms FRONTIERS IN PHARMACOLOGY, 2021, v.12 no.0 , 675300-675300
SCIE
[학술지논문] Caenorhabditis elegans mounts a p38 MAPK pathway-mediated defence to Cutibacterium acnes infection CELLULAR MICROBIOLOGY, 2020, v.22 no.10 , 13234-13234
SCI
[학술지논문] In the Model Host Caenorhabditis elegans, Sphingosine-1-Phosphate-Mediated Signaling Increases Immunity toward Human Opportunistic Bacteria INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, v.21 no.21 , 7813-7813
SCIE
[학술지논문] Multi-omics based characterization of antibiotic response in clinical isogenic isolates of methicillin-susceptible/-resistantStaphylococcus aureus RSC ADVANCES, 2020, v.10 no.46 , 27864-27873
SCIE
[학술지논문] New Antimicrobial Bioactivity against Multidrug-Resistant Gram-Positive Bacteria of Kinase Inhibitor IMD0354 Antibiotics, 2020, v.9 no.10 , 665-665
SCIE
[학술지논문] The Neutrally Charged Diarylurea Compound PQ401 Kills Antibiotic-Resistant and Antibiotic-Tolerant Staphylococcus aureus MBIO, 2020, v.11 no.3 , 114020-114020
SCIE
[학술지논문] A selective membrane-targeting repurposed antibiotic with activity against persistent methicillin-resistant Staphylococcus aureus PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2019, v.116 no.33 , 16529-16534
SCI
[학술지논문] Auranofin is an effective agent against clinical isolates of Staphylococcus aureus FUTURE MEDICINAL CHEMISTRY, 2019, v.11 no.12 , 1417-1425
SCIE

2024-1st
- Food Microbiology
  - Subject No 36311Class No 01
  - 2Year ( 3Credit , 3Hour) Mon 2~3 (ENG )
- Introduction to Pharmaceutical Research
  - Subject No 38940Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-A404)
  - Major Requisite
- Pharmaceutical Microbiology Ⅰ
  - Subject No 38948Class No 01
  - 3Year ( 3Credit , 3Hour) Tue 5~5 (POSCO462) , Thu 5~5 (POSCO462)
  - Major Requisite
- Pharmaceutical Microbiology Ⅰ
  - Subject No 38948Class No 02
  - 3Year ( 3Credit , 3Hour) Tue 2~2 (POSCO552) , Thu 2~2 (POSCO552)
  - Major Requisite
- Pharmaceutical Sciences and Experiment Ⅱ
  - Subject No 38964Class No 01
  - 3Year ( 2Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Sciences and Experiment Ⅱ
  - Subject No 38964Class No 02
  - 3Year ( 2Credit , 3Hour) Tue 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Microbiology Ⅰ
  - Subject No 39053Class No 01
  - 3Year ( 3Credit , 3Hour) Tue 4~4 (POSCO462) , Thu 4~4 (POSCO462)
  - Major Requisite
- Pharmaceutical Sciences and Experiment Ⅱ
  - Subject No 39069Class No 01
  - 3Year ( 2Credit , 3Hour) Wed 6~7 (PHM-A307)
  - Major Requisite
- Infection Control and Molecular Mechanisms
  - Subject No G16858Class No 01
  - Year ( 3Credit , 3Hour) Fri 4~5 (PHM-)
2023-2nd
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 01
  - 3Year ( 3Credit , 3Hour) Tue 2~2 (POSCO552) , Fri 4~4 (POSCO552)
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 02
  - 3Year ( 3Credit , 3Hour) Tue 3~3 (POSCO552) , Thu 6~6 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 5~5 (PHM-A104) , Fri 3~3 (POSCO552)
  - Major Requisite
- Pharmaceutical Experiment II 강의 계획서 상세보기
  - Subject No 37106Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II 강의 계획서 상세보기
  - Subject No 37106Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II 강의 계획서 상세보기
  - Subject No 37106Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A307)
  - Major Requisite
- Advanced Pharmacy Practice and Research I 강의 계획서 상세보기
  - Subject No 37154Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Advanced Pharmacy Practice and Research Ⅱ 강의 계획서 상세보기
  - Subject No 37155Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Advanced Pharmacy Practice and Research Ⅲ 강의 계획서 상세보기
  - Subject No 37156Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Seminar for Pharmaceutical Sciences II
  - Subject No G16888Class No 01
  - Year ( 3Credit , 3Hour) Thu 7~8 (PHM-A400)
- Advanced Pharmaceutical Microbiology II
  - Subject No G16897Class No 01
  - Year ( 3Credit , 3Hour) Mon 2~3 (PHM-)
- Seminar for Pharmaceutical Sciences Ⅱ
  - Subject No G18239Class No 01
  - Year ( 3Credit , 3Hour) Thu 7~8 (PHM-A400)
2023-1st
- Pharmaceutical Microbiology I 강의 계획서 상세보기
  - Subject No 22563Class No 01
  - 3Year ( 1.5Credit , 1.5Hour) Thu 3~3 (PHM-A100-1)
  - Major Requisite
- Pharmaceutical Microbiology I 강의 계획서 상세보기
  - Subject No 22563Class No 02
  - 3Year ( 1.5Credit , 1.5Hour) Fri 6~6 (POSCO551)
  - Major Requisite
- Pharmaceutical Microbiology I 강의 계획서 상세보기
  - Subject No 22563Class No 03
  - 3Year ( 1.5Credit , 1.5Hour) Fri 5~5 (POSCO551)
  - Major Requisite
- Pharmaceutical Experiment II 강의 계획서 상세보기
  - Subject No 37106Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II 강의 계획서 상세보기
  - Subject No 37106Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II 강의 계획서 상세보기
  - Subject No 37106Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A307)
  - Major Requisite
- Introduction to Pharmaceutical Research 강의 계획서 상세보기
  - Subject No 39045Class No 01
  - 2Year ( 1.5Credit , 1.5Hour) Thu 6~6 (PHM-)
- Infection control and molecular mechanisms
  - Subject No G16858Class No 01
  - Year ( 3Credit , 3Hour) Tue 2~3 (PHM-)
2022-2nd
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 01
  - 3Year ( 3Credit , 3Hour) Mon 4~4 (POSCO551) , Fri 4~4 (POSCO551)
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 02
  - 3Year ( 3Credit , 3Hour) Tue 2~2 (POSCO551) , Fri 5~5 (POSCO551)
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 03
  - 3Year ( 3Credit , 3Hour) Mon 3~3 (POSCO551) , Thu 5~5 (POSCO552)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A307)
  - Major Requisite
- Advanced Pharmacy Practice and Research I
  - Subject No 37154Class No 01
  - 6Year ( 4Credit , 200Hour)
  - Major Requisite
- Lab rotation Ⅰ
  - Subject No 38927Class No 01
  - 1Year ( 1.5Credit , 0Hour) Thu 7~7
- Lab rotation Ⅰ
  - Subject No 38927Class No 02
  - 1Year ( 1.5Credit Thu 7~7
- Lab rotation Ⅰ
  - Subject No 39032Class No 01
  - 1Year ( 1.5Credit , 0Hour) Thu 7~7
- Advanced Pharmaceutical Microbiology II
  - Subject No G16897Class No 01
  - Year ( 3Credit , 3Hour) Fri 6~7 (PHM-)
2022-1st
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 01
  - 3Year ( 1.5Credit , 1.5Hour) Thu 5~5
  - Major Requisite
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 02
  - 3Year ( 1.5Credit , 1.5Hour) Fri 6~6
  - Major Requisite
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 03
  - 3Year ( 1.5Credit , 1.5Hour) Fri 5~5
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 01
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 03
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Infection control and molecular mechanisms
  - Subject No G16858Class No 01
  - Year ( 3Credit , 3Hour) Wed 2~3 (PHM-A204)
2021-2nd
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 01
  - 3Year ( 3Credit , 3Hour) Mon 2~2 , Thu 3~3
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 02
  - 3Year ( 3Credit , 3Hour) Tue 2~2 , Thu 2~2
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 03
  - 3Year ( 3Credit , 3Hour) Tue 3~3 , Fri 3~3
  - Major Requisite
- Pharmaceutical Microbiology II
  - Subject No 22565Class No 04
  - 3Year ( 3Credit , 3Hour) Tue 3~3 , Fri 3~3
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 01
  - 3Year ( 1.5Credit , 3Hour) Mon 6~9 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~9 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 03
  - 3Year ( 1.5Credit , 3Hour) Wed 6~9 (PHM-A307)
  - Major Requisite
- Advanced Pharmacy Practice and Research I
  - Subject No 37154Class No 01
  - 6Year ( 4Credit
  - Major Requisite
- Honors research
  - Subject No 37803Class No 01
  - 4Year ( 1Credit , 1Hour)
- Advanced Pharmaceutical Microbiology II
  - Subject No G16897Class No 01
  - Year ( 3Credit , 3Hour) Mon 4~5
2021-1st
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 01
  - 3Year ( 1.5Credit , 1.5Hour) Thu 5~5
  - Major Requisite
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 02
  - 3Year ( 1.5Credit , 1.5Hour) Thu 6~6
  - Major Requisite
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 03
  - 3Year ( 1.5Credit , 1.5Hour) Thu 4~4
  - Major Requisite
- Pharmaceutical Microbiology I
  - Subject No 22563Class No 04
  - 3Year ( 1.5Credit , 1.5Hour) Thu 4~4
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 01
  - 3Year ( 1.5Credit , 3Hour) Wed 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 02
  - 3Year ( 1.5Credit , 3Hour) Tue 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 03
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Pharmaceutical Experiment II
  - Subject No 37106Class No 04
  - 3Year ( 1.5Credit , 3Hour) Mon 6~7 (PHM-A307)
  - Major Requisite
- Industrial Pharmacy & Administrative Pharmacy Practice
  - Subject No 37153Class No 03
  - 6Year ( 2.5Credit
  - Major Requisite

Academic Background

Rensselaer Polytechnic Institute Ph.D.(화학생물공학부)

Seoul Nat'l Univ. 공학석사(화학생물공학부)

Seoul Nat'l Univ. 공학사(화학생물공학부)

Kim, Wooseong Associate Professor

Research Record

Courses

Academic Background